Explore the vast range of titles available.

Background Thorough and standardized documentation of operative notes is essential for effective communication, patient safety, legal protection, and the continuity of care. However, in many hospitals in Sudan, surgeons often use non-standardized methods, resulting in inconsistent and incomplete records. This study evaluates the quality of operative notes at the Port Sudan Teaching Hospital using the Royal College of Surgeons of England (RCSEng) guidelines, aiming to improve compliance and documentation practices. Methods A clinical audit was conducted in two cycles at the General Surgery Department. The first cycle, a retrospective review of 50 surgical notes, was carried out over one week in July 2024. The second cycle conducted prospectively on another 50 notes throughout September 2024, involved the implementation of an improved proforma and staff training. Data were collected using a standardized checklist aligned with Royal College of Surgeons in Ireland (RCSI) guidelines, covering 18 documentation criteria. Results were analyzed using Microsoft Excel 2016 (Microsoft Corporation, Redmond, Washington, United States) to assess improvements in compliance. Results The compliance with documentation standards increased significantly from 51.9% in the first cycle to 82.1% in the second cycle. Notable improvements were observed in recording operative findings (17, 34%), complications (34, 68%), and deep vein thrombosis (DVT) prophylaxis (47, 94%). Despite the overall progress, modest improvements were noted in documenting the anesthetist's name (2.5, 5%) and the surgeon's signature (3, 6%). These findings underscore the positive impact of structured proformas and targeted staff training. Conclusion The implementation of standardized documentation tools and staff training significantly improved the quality of surgical operative notes at the Port Sudan Teaching Hospital. While notable progress was achieved, continued efforts, including digital solutions and regular audits, are needed to sustain these improvements and promote patient safety.

BackgroundThere is a shortage of neurologists at a time when brain disorders have become major contributors to disability and death worldwide. This is the first national study of Egyptian early-career physicians, exploring their attitudes towards neurology and neuroscience.MethodsThis cross-sectional study took place in September and October 2024 using a structured, self-administered online questionnaire, comprising Likert-scale, multiple-choice and closed-ended questions. We calculated the mean and SD for the score of each speciality in different characteristics (ie, interest, difficulty, confidence and knowledge). The concept of neurophobia was defined as a combined confidence and difficulty score of ≤4 points. Data analysis was done using R Statistical Software (V.4.4.2, R Core Team).ResultsOur study included 445 participants, comprising 384 interns (86%), 23 primary care physicians (5.2%) and 38 residents (8.5%). Around 51% of interns and primary care physicians were males, compared with 34% of residents. A total of 205 (50.4%) of the interns and primary care physicians exhibited neurophobia, followed by 197 (48.4%) to cardiology, and 132 (32.4%) to geriatrics. The most common factors for neurophobia were trouble with neuroanatomy (48.9%), lack of curative treatment or poor prognosis (35.6%), too many rare diagnoses (34.2%), poor teaching (25.8%) and trouble with basic neuroscience (22.4%). Interns and primary care physicians showed a moderate likelihood of specialising in neurology with a mean (SD) score of 2.55 (1.09).ConclusionsThe current study provided a summary of residents’ perspectives toward neurology and neuroscience as well as suggestions to combat neurophobia.

Chronic kidney disease (CKD) is commonly complicated by anemia. Treating dialysis-dependent patients with anemia, including daprodustat and other inhibitors of prolyl hydroxylase of hypoxia-inducible factor, recombinant human erythropoietin (rhEPO), and iron supplements. We conducted this study to test our postulation; daprodustat is superior to rhEPO and other conventional treatments respecting efficacy and safety parameters. We made systematic search through PubMed, Web of Science, Scopus, and Cochrane. Seven unique trials were eventually included for systematic review; six of them with a sample size of 759 patients entered our network meta-analysis (NMA). Daprodustat 25-30 mg was associated with the greatest change in serum hemoglobin (MD=1.86, 95%CI= [1.20; 2.52]), ferritin (MD= -180.84, 95%CI= [-264.47; -97.20]), and total iron binding capacity (TIBC) (MD=11.03, 95%CI= [3.15; 18.92]) from baseline values. Dialysis-dependent patients with anemia had a significant increment in serum Hemoglobin and TIBC and a reduction in serum ferritin, in a dose-dependent manner, when administered daprodustat.